Objectives-The first objective of this study was to demonstrate differences within endothelial-dependent and endothelialindependent vasoreactivity in macro-and microcirculation beds among patients with metabolic syndrome (MetS) with and without type 2 diabetes mellitus (T2D) compared with healthy counterparts. The second objective was to determine relationships among the function of macro-and microvascular systems and abdominal adiposity, as well as inflammatory markers in the 3 groups. Approach and Results-Cross-sectional analyses of 53 patients with MetS without T2D and 25 with T2D, as well as aged 40 years and sex-matched healthy controls included microvascular (cutaneous blood flow measured with laser Doppler flowmetry in response to iontophoresis of acetylcholine and sodium nitroprusside), and macrovascular reactivity (flowmediated dilation and nitrate-mediated dilation) along with anthropometric measures, plasma glucose, and insulin and inflammatory markers. Compared with controls, MetS participants showed depressed endothelial function of both microand macrocirculation beds. T2D in patients with MetS revealed an exacerbated vascular smooth muscle dysfunction in micro-and macrocirculation compared with MetS without T2D. Indices of micro-and macrocirculation were predominantly inversely related to abdominal fat and inflammatory markers. Conclusions-MetS was associated with endothelial-dependent and endothelial-independent dysfunction, affecting both the macro-and the microvascular systems. Participants with diabetes mellitus demonstrated the most severe smooth muscle dysfunction. The presence of central abdominal fat and systemic inflammation seems implicated in the pathogenesis of vascular dysfunctions in MetS.
M etabolic syndrome (MetS) is a clustering of cardiovascular risk factors, including central obesity, impaired fasting glucose, dyslipidemia, and hypertension. It is a key phenotype leading to atherogenic and diabetogenic profiles. Endothelial and vascular smooth muscle dysfunction are considered early abnormalities in the development of atherosclerotic process in cardiometabolic disease. 1, 2 The vascular endothelium plays a pivotal role in maintaining vascular protective conditions and controlling smooth muscle tone. Specifically, control is managed through the release of potent vasodilators, such as nitric oxide (NO). Investigation of endothelial-derived NO function in large human vessels, through the noninvasive technique of flow-mediated dilation (FMD), has been largely used to predict cardiovascular outcomes in patients at risk of developing cardiovascular diseases (CVDs). In this context, MetS has been well characterized by morphological and functional disorders within large-sized vessels. [3] [4] [5] However, most of the arterial vasculature is the nutritive network of smaller vessels (arterioles and capillaries), known as resistance arteries. These resistance arteries have a dominant influence on local blood flow (BF) and are directly connected with other tissues. Also, resistance arteries are submitted to chemical and neurohormonal stimulation and exposed to the continuous effects of shear stress generated by the blood stream. 6 Moreover, emerging evidence suggests that coronary microvascular disease may appear before macrovascular disease in cardiometabolic disease, highlighting the relevance of early detection and comprehensive investigation of both micro-and macrovascular dysfunction. 7 In patients with type 2 diabetes mellitus (T2D), microvascular and macrovascular dysfunction frequently coexist and are thought to be mediated, in part by reduced NO bioavailability [8] [9] [10] resulting in progressive tissue damage. Nevertheless, in addition to the endothelium, vascular smooth muscle needs to be considered as a potential cause of vascular dysfunction in T2D, as recently demonstrated in a meta-analysis. 11 Data about MetS microcirculation function are scarce and conflicting. Skin microvascular abnormalities in response to ischemia have been observed in individuals with MetS. 12, 13 More comprehensive studies have also observed endothelium-dependent dysfunction at a cutaneous 5, 14, 15 and subcutaneous levels. 16 However, only 1 study 14 has also reported smooth muscle cell dysfunction in the skin microcirculation. What remains unknown is whether the presence of diabetes mellitus is a confounder in microand macrovascular dysfunction of individuals with MetS. Studies to date have failed to include MetS individuals without T2D. Subsequently, it also remains uncertain whether associated micro-and macrovascular dysfunction is present in MetS individuals in a prediabetic state (ie, without T2D).
The links between vascular pathophysiology and abdominal obesity-related inflammation are also an emerging interest. Specifically, MetS has been linked to visceral abdominal fat that is recognized as a passive fat storehouse with high capacities of adipokines synthesis, leading to proinflammatory and insulin-resistant states. 17 The link could explain, at least in part, macro-and microcirculatory impairments reported in this population in cutaneous and in subcutaneous vascular beds. 5, [12] [13] [14] 16 Nevertheless, to the best of our knowledge, whether abdominal obesity and inflammation are associated with both macro-and microcirculation NO-related pathway in patients with MetS remains unknown.
Therefore, the first aim of this study was to compare endothelial-dependent and endothelial-independent vasoreactivity within macro-and microcirculation beds among patients with MetS with (MetS-T2D) and without T2D (MetS-NT2D) compared with healthy counterparts. The second aim was to explore relationships among the function of macro-and microvascular systems and abdominal adiposity and inflammatory markers in the 3 groups.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Anthropometric and Metabolic Variables
Patients with MetS and controls were matched for age and sex distribution (Table 1) . Smoking history and medication distribution did not differ between MetS groups. Compared with controls, MetS individuals presented with significantly higher body mass index, body mass components, systolic arterial pressure, waist circumference, fasting glucose, glycohemoglobin, triglycerides, insulin and homeostatic model assessment of insulin resistance, whereas high-density lipoprotein cholesterol was lower in MetS. Similarly, all inflammatory markers were higher in MetS groups than in controls (Table 1 ). However, comparisons of the 2 MetS groups showed greater values for waist circumference, fasting glucose, glycohemoglobin, insulin, homeostatic model assessment of insulin resistance, and active plasminogen activator inhibitor-1 in MetS-T2D than in MetS-NT2D.
Vascular Structure and Endothelium-Dependent and Endothelium-Independent Function
In the microcirculation, resting cutaneous BF (CBF) did not differ among the 3 groups. CBF peak and the relative increase (CBF %), as well as the increase in cutaneous vascular conductance (%) in response to acetylcholine (ACh) iontophoresis, were lower in MetS individuals than in controls. Similar results were observed in CBF responses to sodium nitroprusside (SNP) iontophoresis in MetS groups and controls (Table 2) , with the exception of the relative increase ( Figure 1 ). Compared with MetS-NT2D, MetS-T2D had lower SNP-induced reactivity (CBF % and cutaneous vascular conductance %), without differences in ACh responses (Table 2; Figure 1 ). Results from the vascular assessments in the brachial artery showed significantly lower FMD values in MetS than in controls. In contrast, resting brachial artery diameter, resting and peak BF, and resting and peak shear rate were similar among the 3 groups (Table 2; Figure 1 ). Normalization of FMD using the ∆shear adjustments yielded similar values among groups. Lower nitrate-mediated dilation (NMD) of the brachial artery was observed more frequently in MetS individuals than in the healthy controls. However, within the MetS groups, an exacerbated NMD dysfunction was observed in MetS-T2D than in MetS-NT2D ( Figure 1 ). When macro-and microcirculation endothelium-dependent dilation (ACh and FMD) was adjusted for maximal dilatation (SNP and NMD), MetS individuals showed lower endothelium-dependent dilation index in small and large vessels than controls, without any apparent effects of T2D ( Figure 2 ).
Relationships Between Endothelium-Dependent and Endothelium-Independent Parameters and Clinical Data
Linear regression and correlation analyses were performed to examine the relationships between endothelium-dependent Nonstandard Abbreviations and Acronyms and endothelium-independent dilation in macro-and microcirculation, as well as clinical and inflammatory parameters. A relationship between ACh CBF increase (%) and brachial FMD (%; r=0.51; P<0.001) was observed and persisted when either ACh iontophoresis CBF or peak ACh cutaneous vascular conductance was used in the model. No correlation was observed between SNP transdermal iontophoresis and NMD (P>0.05). Table 3 presents other significant correlates of clinical data and endothelium-dependent and endothelium-independent dilatation in macro-and macrocirculation. In multiple regression analyses, ACh CBF increase, central fat and active plasminogen activator inhibitor-1 emerged as independent predictors of FMD, explaining 30% (P<0.0001) of observed variance. Central fat emerged as a unique independent predictor of the CBF responses to ACh and SNP iontophoresis, explaining, respectively, 17% (P<0.0001) and 8% (P=0.003) of observed variance. No variables were retained in the multiple regression model relating to the NMD response. Values are mean±SD. P value was estimated using a 1-way ANOVA followed by a post hoc Tukey multiple comparison test. For demographic, medications, and smoking history parameters, χ 2 test was used to verify the distribution within each group of participants. BMI indicates body mass index; HbA 1c , glycated hemoglobin; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; LDL, low-density lipoprotein; MetS-T2D: Metabolic syndrome patients with type 2 diabetes mellitus; MetS-NT2D, metabolic syndrome individuals without type 2 diabetes mellitus; PAI-1, plasminogen activator inhibitor-1; and TNFα, tumor necrosis factor α.
*P<0.05 vs controls, †P<0.05 vs MetS-NT2D, ‡Data are log or square-root transformed to satisfy Gaussian distribution.
Discussion
Three major findings emerged from this study are as follows: (1) individuals diagnosed with MetS but without T2D exhibited depressed vascular function in both macro-and microvascular beds with serious implications for NO pathway. (2) The presence of T2D in MetS participants exacerbated the smooth muscle dysfunction in large and small vessels with no additional effect on endothelial function.
(3) In association with abdominal obesity, inflammation and glucose intolerance were correlated with the vascular dysfunction, especially when the NO endothelium-dependent pathway was considered in the large brachial artery and skin microcirculation. These findings strengthen the evidence base for investigations into early generalized endothelial and vascular smooth muscle dysfunction in prediabetic MetS individuals to limit the risk of developing atherosclerosis disease. Because endothelial dysfunction is a systemic disorder, peripheral vascular beds represent convenient access and require less elaborate equipment than assessments involving the vasoreactivity of coronary arteries. FMD has been widely used to assess vascular function and is a demonstrated predictor of CVD. 18 However, vascular dysfunction may occur differentially in vascular beds. Specifically, endothelial cells differ in phenotype and structure depending on vessel type and have also produced heterogeneous responses to ex vivo isolated arteries investigation. 19 Skin microcirculation has, therefore, been proposed as a model of systemic microvascular function to permit investigation of underlying mechanisms in CVD. 6, 20 Systemic vascular disorders have been assessed by skin capillary density and pulse wave velocity in MetS, but the functional underlying mechanisms remained uncertain. 5 Thus, to our knowledge, the current study focuses on an association between macro-and microvascular NO reactivity in MetS. It also demonstrates that not only endothelium NO-dependent but also endothelium NO-independent vasodilation impairments coexist, even without the presence of T2D. Our findings in the brachial artery (ie, FMD) are in accordance with the Framingham 3 and other studies in MetS individuals, reporting endothelial-dependent dysfunction, independent of age and sex. 4, 21, 22 Previous studies in T2D have postulated that microvascular dysfunction might cause an insufficient increase in shear stress to stimulate the endothelial NO release, demonstrated by lower FMD. 23 Indeed, investigations into small vessels in the current study showed that CBF was decreased in response to ACh in MetS with and without T2D when compared with controls. This suggested the presence of an impairment of NO-related endothelial function in the microvasculature in accordance with previous studies in skin and abdominal subcutaneous microcirculation. 14, 16 Moreover, a strong correlation was previously reported from an investigation into the endothelial function of the skin microcirculation in response to ACh iontophoresis and the brachial arterial endothelial reactivity assessed by FMD, in a nonselected population. 24 We observed a more modest correlation (r=0.51; P<0.001), which could be explained by our well-phenotyped MetS participants.
We postulate that both NO synthesis pathways are affected by MetS with or without the presence of T2D. Nevertheless, this endothelium-dependent dysfunction has to be interpreted with caution, given that the endothelium-dependent response includes, at least in part, the function of the smooth muscle. Indeed, our results indicate that the smooth muscle response to exogenous organic nitrate is impaired in the brachial artery (NMD) and microvasculature (SNP) of patients with MetS. To Values are mean±SD. P value was estimated using a 1-way ANOVA followed by a post hoc Tukey multiple comparison test. ∆shear rate means peak brachial shear rate minus resting brachial shear rate. ACh indicates acetylcholine; CBF, cutaneous blood flow; CVC, cutaneous vascular conductance; FMD, flow-mediated dilation; MetS-NT2D, metabolic syndrome individuals without type 2 diabetes mellitus; MetS-T2D, metabolic syndrome individuals with type 2 diabetes mellitus; and SNP, sodium nitroprusside. *P<0.05 vs controls; †P<0.05 vs MetS-NT2D.
minimize confusion in the results, we used an endotheliumdependent dilation index to isolate the part of vessel dilation attributed to the endothelium. When compared with healthy participants, we observed a decreased endothelium-dependent dilation index in patients with MetS showing an intrinsic endothelial-dependent dysfunction independently of smooth muscle cell vasodilation reserve, and without an exacerbated effect of T2D. In contrast to the current study, previous studies have been unable to describe smooth muscle dysfunction in MetS either during in vitro studies of the abdominal subcutaneous small vessels 16 or in vivo in the skin microcirculation. 5, 15 These discrepancies could be explained by the inclusion of different tissues, or, a low number of participants in the first study. 16 In the other 2 studies, 5,15 the lack of insulin resistance or T2D among participants that was associated with the absence of cutaneous vascular dysfunction may have limited the capacity to describe smooth muscle dysfunction in MetS. When compared with the healthy controls, macrocirculation and microcirculation responses were, respectively, 24.1% and 32.2% lower in MetS-T2D and 13.5% and 8.0% in MetS-NT2D. These results are in accordance with our recent meta-analysis, showing that vascular smooth muscle function was more compromised in the microcirculation than in the macrocirculation of T2D individuals. 11 Accordingly, the aggravation of vascular smooth muscle dysfunction observed in the microcirculation of individuals with T2D may be a distinctive feature of this metabolic disorder. However, this result has only previously been reported in animals. 25 Thus, we also postulate that individuals with MetS-T2D are at higher risk of developing CVD than previously thought because vascular smooth muscle dysfunction has been proposed as a predictor of future cardiovascular events, with greater sensitivity than endothelial function. 2, 26 Advancing the understanding the pathophysiological link between macro-and microvasculature dysfunction in individuals with MetS is complex because MetS is a cluster of symptoms. In this context, we also observed that mean arterial pressure is correlated with macrovasculature endothelial function. Microvascular dysfunction is generally presented as a consequence of hypertension that could contribute to lower capillary density 27 and arteriolar constriction, essentially mediated through higher endothelin-1 synthesis. 28 However, recent evidence points to impaired microvasculature increasing peripheral resistance, possibly contributing to the development of high blood pressure in large vessels. In agreement with this hypothesis, we reported lower cutaneous vascular conductance response to ACh and SNP iontophoresis in MetS participants, indicating higher skin microcirculation resistance, as well as a significant correlation between mean arterial pressure and FMD. Interestingly, we also observed that CBF in response to ACh iontophoresis was an independent predictor of conduit artery endotheliumdependent vasodilation in patients with MetS. Thus, once installed, hypertension may lead to arteriolar wall remodeling and exacerbate microvascular function. 7 Previous studies in patients with MetS without hypertension reported endothelium-dependant dysfunction in microcirculation. 5, 16 However, because the current study was only cross-sectional and most of our participants were hypertensive (73%), additional studies are needed to understand the complex interplay between microvascular dysfunction and chronic hypertension better. Because microvessels and surrounding tissues are highly coupled, this functional study of microcirculation related to metabolic risk factors has generated much interest. However, the understanding of their association with vascular tree dysfunction in MetS remains incomplete. In the present study, central fat or active plasminogen activator inhibitor-1 proinflammatory cytokine emerged as independent predictors of FMD and CBF response to ACh and SNP iontophoresis. Several hypotheses, which align with the present study's findings, may help elucidate these mechanisms. Increasing evidence supports the role of abdominal adiposity in active endocrinologic functions via dysfunctional adipocytes by promoting a proinflammatory state leading to pertubated vascular homeostasis. 29 Increased body mass index, central fat, adipokine levels, and decreased adiponectin were observed in our MetS participants, and significant relationships were shown between some markers of systemic inflammation, such as active plasminogen activator inhibitor-1, interleukin-6, high-sensitivity C-reactive protein, and tumor necrosis factor α and endothelium-dependent and endothelium-independent function in both macro-and microvascular beds. Elevated proinflammatory cytokines could explain the depressed vascular dysfunction in macro-and microcirculation beds. This may occur via the known deleterious effect of adipokines on many responses: (1) endothelial NO synthase expression in the endothelial cell resulting in lower NO synthesis and increased endothelin-1, 30 (2) the anticontractile properties of healthy adipose tissue surrounding blood vessels, 31 (3) higher proliferation and contractility of vascular smooth muscle cells, 32 or (4) tetrahydrobiopterin bioavailability resulting in endothelial NO synthase uncoupling, leading to an increase in superoxide anion production and inhibition of endothelial NO synthase/ cGMP signaling. 33 Nonetheless, it must be considered that our study was performed in vivo during normal circulation in humans, and it was not possible to gain more direct insights into release of cytokines. Additional studies are needed to understand the cross talk between proinflammatory tissue and vascular function better.
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Limitations
The present study has limitations. The cutaneous microcirculation may raise questions about its overall significance for small vessel assessment. However, there is a substantial literature indicating that cutaneous microvascular function mirrors generalized systemic microvascular function. 20 Capillary density measures would also be interesting to measure because capillary rarefaction seems implicated with microvascular dysfunction. Further prospective studies are required to clarify this issue. Acquiring the levels of NO may have provided greater insight into the characteristics of our groups in relation to vascular function measures, but this parameter was not measured in this study. Vasoreactivity assessment includes SNP, FMD, and NMD that are NO dependent. 34 However, NO inhibition reduces only 30% to 40% of the microvascular vasodilatory response induced by ACh, 35 suggesting that other factors may contribute to vasodilation in the resistance vessels. Another limiting factor was the use of existing or previous medical treatments of our participants, which could also have affected vascular function and circulating markers. However, there were no significant alterations to the results when medication and smoking history or status were accounted for (data not shown).
Conclusions
Our study provides new insights into the mechanisms that may contribute to the pathogenesis of vascular dysfunction in prediabetic MetS without a history of incompatible diseases, such as CVD. Overall, we demonstrated generalized vasoreactivity impairment in patients with MetS even without T2D, with an exacerbated dysfunction in vascular smooth muscle reactivity in patients with MetS and T2D. The presence of fat, especially central and systemic inflammation, seems to be implicated in the pathogenesis of vascular dysfunctions in MetS. Overall, Table 3 ACh indicates acetylcholine; CBF, cutaneous blood flow; FMD, flow-mediated dilation; HbA 1c , glycated hemoglobin; HDL, high-density lipoprotein; high-sensitivity C-reactive protein; IL-6, interleukin-6; NMD, nitrate-mediated dilation; PAI-1, plasminogen activator inhibitor-1; SNP, sodium nitroprusside; and TNFα, TNFα, tumor necrosis factor α.
. Relationships Between Micro-and Macrocirculation Endothelium-Dependent and Endothelium-Independent Dilation and Clinical and Inflammatory Parameters
the clinical implications of investigating macro-and microcirculatory responses are of interest because our findings extrapolated to other cardiovascular functions and could explain the early recognition of increased risk of CVD in MetS.
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